The Latest Breaking News from VRTX

Minerva Neurosciences (NERV) and Vertex Pharmaceuticals (VRTX) are expected to benefit from the rising number of chronic diseases and continued technological advancements in the industry. Since NERV has gained more than 100% this week, is it a better investment than VRTX? Read more to find out….

Dow Jones futures fell as the market rally pulls back with Bitcoin tumbling. BBBY stock dived in a "reversion to the meme."

Vertex Pharmaceuticals is showing is showing green check marks across the board, and today we will look at a bullish option strategy.

Vertex Pharmaceuticals made a bullish move on earnings amid a confirmed market rally, leading five stocks to watch this week.

The indexes were quiet before the July jobs report tests the Fed's soft landing. Tesla shareholders OK'd a 3-for-1 stock split.

Vertex Pharmaceuticals said its triple-regimen in cystic fibrosis is gaining new users abroad. VRTX stock jumped Friday.

Investors’ sentiment is significantly mixed at the moment, with market volatility at its peak. It could be wise to buy quality stock Vertex Pharmaceuticals (VRTX), which possesses robust financials. However, fundamentally weak stock NeoGenomics (NEO) is best avoided now. Read on….

In an uncertain market environment, investors must look for stocks that could win in the long run based on their strong fundamentals and solid growth prospects. We think Walmart (WMT), Tennant (TNC), Commvault Systems (CVLT), and Vertex Pharmaceuticals (VRTX) could be good choices on that front. Read on to learn…

Leading biotechnology company Vertex Pharmaceuticals (VRTX) has achieved strong top and bottom-line growth in its last quarter. Furthermore, the company is well-positioned to benefit from its diversified pipeline of transformative small-molecule, cell, and genetic therapies. Thus, even after gaining 27.5% year-to-date, we think VRTX still has decent upside potential. Read…